Research findings on quality of clarithromycin in the Kenyan market - Are the generics as good as the innovator brand?
Printer-friendly versionPDF version
Date and time: 
Thu, 2018-05-24 11:55

In a study  conducted by Dr. Manani and co-workers, on the pharmaceutical equivalence of clarithromycin oral dosage forms marketed in Nairobi County, Kenya found out that a significant percentage of generic clarithromycin products are pharmaceutically non-equivalent to the innovator products, and that assay and single-point dissolution tests are insufficient demonstration of equivalence between the generic and innovator products.

The fndings were publised by Scientia Pharmaceutica, a high impact journal of the mdpi. The peer-reviewd article can be freely accessible at:



Expiry Date: 
Thu, 2019-05-23 11:55